Omnilife-Chivas establishes U.S. manufacturing facility to mitigate tariff exposure

Omnilife-Chivas is opening a production plant in the United States to circumvent a 25 percent export surcharge. This move represents a strategic shift to localize supply chains and avoid trade barriers, though the specific location and operational timeline remain unconfirmed.